Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Recruiting 1Not yet recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Prostatic Neoplasms 219Urinary Bladder Neoplasms 55Carcinoma, Renal Cell 50Non-Muscle Invasive Bladder Neoplasms 26Kidney Neoplasms 26Neoplasms 25Carcinoma, Transitional Cell 17Breast Neoplasms 16Adenocarcinoma 15Melanoma 11Neoplasm Metastasis 10Disease 9Clear-cell metastatic renal cell carcinoma 8Uterine Cervical Neoplasms 7Stomach Neoplasms 7Lung Neoplasms 7Endometrial Neoplasms 7Colorectal Neoplasms 7Testicular Neoplasms 6Recurrence 6Carcinoma, Non-Small-Cell Lung 6Urologic Neoplasms 5Urinary Incontinence 5Pancreatic Neoplasms 5Ovarian Neoplasms 5Head and Neck Neoplasms 5Acute Kidney Injury 5Triple Negative Breast Neoplasms 4Sarcoma 4Penile Neoplasms 4

Interventions

Pluvicto 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Not yet recruiting × High-Risk Localized Prostate Cancer × Genitourinary × Clear all
NCT07550517 2026-04-24

PSMA-High: EBRT/ PSMA617/ ADT vs. EBRT/ ADT

Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

Phase 2 Not yet recruiting
60 enrolled
Genitourinary

High-Risk Localized Prostate Cancer

Data powered by HemOnc (CC BY 4.0) Colophon âš¡